Efficacy and Safety of a Fully Covered Self-Expandable Metal Stent for Unresectable HCC
Malignant Biliary Obstruction, Hepatocellular Carcinoma
About this trial
This is an interventional treatment trial for Malignant Biliary Obstruction focused on measuring Self expandable metal stent
Eligibility Criteria
Inclusion Criteria: Adults aged 19 years or older, those who consented to the clinical research participation and signed a written consent form Obstructive jaundice caused by unresectable hepatocellular carcinoma Exclusion Criteria: Patients who have previously undergone surgical biliary drainage Patients who need to remain percutaneous transhepatic biliary drainage Patients whose life expectancy is less than 3 months (BCLC stage D without a treatment plan for hepatocellular carcinoma) Patients who cannot undergo endoscopic procedure according to the judgment of the researcher
Sites / Locations
- Seoul National University HospitalRecruiting
Arms of the Study
Arm 1
Experimental
fully covered self-expanable metal stent with HCC
This prospective cohort is comprised of patients with malignant biliary obstruction caused by hepatocellular carcinoma who were treated with endoscopic biliary drainage using fully covered self expandable metal stent.